A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer. [electronic resource]
Producer: 20040525Description: 1114-24 p. digitalISSN:- 1619-7070
- Body Burden
- Bone Marrow -- pathology
- Bone Neoplasms -- diagnosis
- Computer Simulation
- Etidronic Acid -- administration & dosage
- Humans
- Injections, Intravenous
- Male
- Models, Biological
- Organometallic Compounds
- Prognosis
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- diagnosis
- Radiometry -- methods
- Radionuclide Imaging
- Radiopharmaceuticals -- administration & dosage
- Radiotherapy Planning, Computer-Assisted -- methods
- Relative Biological Effectiveness
- Rhenium -- administration & dosage
- Statistics as Topic
- Treatment Outcome
- Whole-Body Counting -- methods
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.